26 August 2010, 5:00 am
SAN DIEGO, CA--(Marketwire - 08/26/10) - Cypress Bioscience, Inc. (NASDAQ: CYPB - News ), a pharmaceutical company engaged in the development of innovative drugs to treat central nervous system (CNS) disorders, today announced that it has acquired patent rights and technology related to a novel, intranasal formulation of carbetocin, a potential breakthrough treatment for the core symptoms of ...... Read More »